These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1. Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448 [TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Oliva E; Young RH; Amin MB; Clement PB Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617 [TBL] [Abstract][Full Text] [Related]
4. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321 [TBL] [Abstract][Full Text] [Related]
5. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Dundr P; Gregová M; Hojný J; Krkavcová E; Michálková R; Němejcová K; Bártů M; Hájková N; Laco J; Mára M; Richtárová A; Zima T; Stružinská I Virchows Arch; 2022 Feb; 480(2):281-291. PubMed ID: 34626221 [TBL] [Abstract][Full Text] [Related]
6. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789 [TBL] [Abstract][Full Text] [Related]
8. Fusion of HMGA2 to COG5 in uterine leiomyoma. Velagaleti GV; Tonk VS; Hakim NM; Wang X; Zhang H; Erickson-Johnson MR; Medeiros F; Oliveira AM Cancer Genet Cytogenet; 2010 Oct; 202(1):11-6. PubMed ID: 20804914 [TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600 [TBL] [Abstract][Full Text] [Related]
10. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant]. Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994 [TBL] [Abstract][Full Text] [Related]
11. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing. Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144 [TBL] [Abstract][Full Text] [Related]
12. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763 [TBL] [Abstract][Full Text] [Related]
13. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Mehine M; Kaasinen E; Heinonen HR; Mäkinen N; Kämpjärvi K; Sarvilinna N; Aavikko M; Vähärautio A; Pasanen A; Bützow R; Heikinheimo O; Sjöberg J; Pitkänen E; Vahteristo P; Aaltonen LA Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1315-20. PubMed ID: 26787895 [TBL] [Abstract][Full Text] [Related]
14. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior. Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555 [TBL] [Abstract][Full Text] [Related]
15. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy. Äyräväinen A; Pasanen A; Ahvenainen T; Heikkinen T; Pakarinen P; Härkki P; Vahteristo P Hum Reprod; 2020 Oct; 35(10):2237-2244. PubMed ID: 32829387 [TBL] [Abstract][Full Text] [Related]
16. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1. Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045 [TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in leiomyomas of deep soft tissue. Panagopoulos I; Gorunova L; Brunetti M; Agostini A; Andersen HK; Lobmaier I; Bjerkehagen B; Heim S Oncotarget; 2017 Jul; 8(30):48769-48781. PubMed ID: 28591699 [TBL] [Abstract][Full Text] [Related]
18. MED12 is frequently mutated in ovarian and other adnexal leiomyomas. Li Z; Maeda D; Kudo-Asabe Y; Tamura D; Nanjo H; Hayashi A; Ikemura M; Fukayama M; Goto A Hum Pathol; 2018 Nov; 81():89-95. PubMed ID: 29944972 [TBL] [Abstract][Full Text] [Related]
19. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480 [TBL] [Abstract][Full Text] [Related]
20. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]